GLP-1 Basics

Clinic-led care provides medical oversight, personalised dosing, and ongoing support—not just medication. This approach helps improve outcomes, manage side effects, and ensure treatment is aligned with your overall health, not just weight loss.

GLP-1 injections are typically taken once weekly. Your clinician will explain how to self-administer the medication and provide ongoing support throughout treatment.

There is no rigid diet required, but GLP-1 therapy works best when paired with healthy lifestyle habits. Many programs include guidance on nutrition, movement, and behaviour to support long-term success.

GLP-1 therapy is often used as part of a longer-term weight management plan. Your clinician will regularly review progress and help determine the appropriate duration of treatment based on your goals and health.

Semaglutide and tirzepatide are both FDA-approved medications used to support weight loss and improve blood sugar control, but they work in slightly different ways.

Semaglutide works by activating one hormone (GLP-1) that helps regulate appetite, slow digestion, and reduce cravings. This leads to feeling full sooner and eating less.

Tirzepatide activates two hormones (GLP-1 and GIP), which may provide stronger appetite control and improved metabolic support. Because of this dual action, some patients experience greater weight loss with tirzepatide.

The most suitable option depends on individual health factors, goals, and how your body responds, which is why medication choice is always determined through a clinician-led consultation.

GLP-1 injections are prescription medications that support weight loss by regulating appetite, slowing gastric emptying, and improving insulin sensitivity. They work with your body’s natural hormones to help reduce hunger and support sustainable weight management.

GLP-1 medications help you feel fuller for longer, reduce cravings, and support better blood sugar control. This makes it easier to maintain healthier eating patterns without extreme restriction or constant hunger.

GLP-1 therapy may be suitable for adults who have struggled with weight despite lifestyle changes or who have weight-related health concerns. Suitability is always determined through a medical consultation to ensure treatment is safe and appropriate.

Many patients notice reduced appetite within the first few weeks. Weight loss typically occurs gradually over several months, with results improving as dosing is carefully adjusted and supported by clinical guidance.

When prescribed and monitored by a qualified medical professional, GLP-1 injections are considered safe and well-studied. Ongoing medical oversight helps manage side effects and ensures treatment remains appropriate over time.